Scale Capital

Scale Capital is a Copenhagen-based venture fund focused on investing in early-stage Nordic B2B tech startups, particularly those with ambitions to scale in the U.S. market. Established in 2012, Scale Capital provides both capital and hands-on strategic support to its portfolio companies, helping them navigate growth challenges and international expansion. The firm typically invests between €1-4 million, with follow-on rounds potentially bringing the total investment per company to €8 million. Scale Capital’s investment themes include digitization, disruptive technologies, deep tech, digital health, and industrial technology. They are known for their active, partnership-driven approach, often working closely with startup teams for several months before making a commitment. This approach allows them to align strategies and ensure mutual compatibility with the founders. Some of their notable investments include Airtame, Be My Eyes, and Alex Therapeutics. The firm operates out of Copenhagen, with additional offices in Stockholm and Silicon Valley, giving it a strong transatlantic presence. Scale Capital aims for a 10-20% ownership share in its portfolio companies and prefers to lead seed rounds while co-leading in Series A. Founders looking to pitch should focus on strong proof of concept, concise business models, and clear market estimates.